Clinical trial
Markers for Glycaemic Control and Continuous Glucose Monitoring in Persons With Type 2 Diabetes on Peritoneal Dialysis
NCT04125160 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Markers for Glycaemic Control and Continuous Glucose Monitoring in Persons With Type 2 Diabetes on Peritoneal Dialysis
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 12, 2019
- Completion date
- September 3, 2020
- Enrollment
- 54 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
continuous glucose monitoring, fructosamine, glycated albumin, hba1c, peritoneal diseases